HTA99 Expert Validation on Proposed Framework for Differentiated HTA Criteria for Rare Disease Drugs in Brazil
Abstract
Authors
L.V. Biglia A. Felippini T.B. Ribeiro T.D.M. Lima P. Aguiar
L.V. Biglia A. Felippini T.B. Ribeiro T.D.M. Lima P. Aguiar
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now